Nattokinase Fibrinolytic Enzyme from Japan
Nattokinase ferment from natto bacteria, used therapeutically for blood clot prevention in cardiovascular patients. Under 3002.90.10.00 as a culture-derived ferment for human prophylactic applications.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Cardiovascular claim substantiation docs for therapeutic status
• Exclude from blood fraction if not immunological per notes
• Fermentation batch consistency reports